Aker BioMarine has announced that its next-generation brain health ingredient, Lysoveta, has been named the Innovation Winner at the Complementary Medicines Australia (CMA) Annual Conference and 26th Industry Awards in Sydney.
This recognition honours the company’s groundbreaking scientific innovation, showcasing its advanced research, technology and unique delivery format that empower brands to offer best-in-class brain health solutions in Australia and around the world.
Lysoveta is the first and only LPC dietary ingredient proven to cross the blood-brain barrier through the Mfsd2a transporter.
By doing so, it delivers essential omega-3 fatty acids DHA and EPA directly to the brain along with critical phospholipids and choline.
These nutrients are critical for supporting memory, mood, focus, stress resilience and overall cognitive performance.
By unlocking this unique and biologically preferred delivery pathway, Lysoveta is not just another supplement; it’s a scientific innovation and game-changer for brain health and long-term wellbeing.
The CMA Annual Conference in Sydney brought together industry leaders, researchers and policy experts to explore The Future of Wellness and Longevity, highlighting innovations, consumer trends, scientific breakthroughs and regulatory landscapes shaping the decades ahead.
From advances in preventative health and personalised nutrition to breakthroughs in healthy ageing, the conference showcased how complementary medicines can continue to play a leading role in supporting quality of life, extending healthspans and meeting the needs of future generations.
"This recognition is a proud milestone for our entire team," said Ross Norris, General Manager, Asia Pacific at Aker BioMarine.
"Aker BioMarine greatly values our partnership with the CMA, whose leadership in ensuring consumers have access to safe, high-quality products aligns with our commitment to advocating for the industry, promoting research and innovation and upholding the highest standards of quality and safety."
"Being honoured with the CMA Innovation Award is a strong validation of our scientific approach and commitment to developing truly innovative solutions across multiple ingredient platforms."